Chiome Bioscience Inc. (4583.T)
JPY 272.0
(-3.2%)
JPY 272.0
(-3.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 682.46 Million | 630.81 Million | 712.93 Million | 480.85 Million | 447.57 Million |
| Cost of Revenue | 283.86 Million | 281.95 Million | 290.47 Million | 235.58 Million | 162.92 Million |
| Gross Profit | 398.59 Million | 348.85 Million | 422.45 Million | 245.27 Million | 284.64 Million |
| Operating Expenses | 1.6 Billion | 1.6 Billion | 1.75 Billion | 1.52 Billion | 1.68 Billion |
| Selling, General and Administrative Expenses | 551.85 Million | 471.89 Million | 444.58 Million | 372.3 Million | 387.51 Million |
| Research and Development Expenses | 1.05 Billion | 1.13 Billion | 1.31 Billion | 1.15 Billion | 1.29 Billion |
| Other Expenses | - | 20.25 Million | 6.61 Million | 4.24 Million | - |
| Cost and Expenses | 1.88 Billion | 1.88 Billion | 2.04 Billion | 1.76 Billion | 1.84 Billion |
| Operating Income | -1.2 Billion | -1.25 Billion | -1.33 Billion | -1.28 Billion | -1.4 Billion |
| Interest Expense | 2.06 Million | 1.32 Million | 1.31 Million | 967 Thousand | - |
| Income Tax Expense | 5.01 Million | 5.01 Million | 13.49 Million | 3.24 Million | 2.42 Million |
| Earnings before Tax | -1.21 Billion | -1.23 Billion | -1.46 Billion | -1.29 Billion | -1.4 Billion |
| Net Income | -1.22 Billion | -1.24 Billion | -1.47 Billion | -1.29 Billion | -1.4 Billion |
| Earnings Per Share Basic | -24.62 | -28.26 | -36.74 | -36.06 | -44.61 |
| Earnings Per Share Diluted | -24.62 | -28.26 | -36.74 | -36.06 | -44.61 |
| Weighted Average Shares Outstanding | 49.54 Million | 43.98 Million | 40.27 Million | 35.87 Million | 31.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.54 Million | 43.98 Million | 40.27 Million | 35.87 Million | 31.47 Million |
| Gross Margin | 0.58 | 0.55 | 0.59 | 0.51 | 0.64 |
| EBIT Margin | -1.78 | -1.97 | -1.86 | -2.68 | -3.12 |
| Profit Margin | -1.79 | -1.97 | -2.08 | -2.69 | -3.14 |
| EBITDA | -1.21 Billion | -1.23 Billion | -1.46 Billion | -1.28 Billion | -1.39 Billion |
| Earnings Before Tax Margin | -1.77 | -2.00 | -1.87 | -2.67 | -3.13 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 134.08 Million | 129.64 Million | 682.46 Million | 158.44 Million | 165.13 Million | 189.48 Million |
| Cost of Revenue | 56.32 Million | 72.64 Million | 283.86 Million | 66.93 Million | 66.72 Million | 76.74 Million |
| Gross Profit | 77.75 Million | 56.99 Million | 398.59 Million | 91.5 Million | 98.41 Million | 112.73 Million |
| Operating Expenses | 336.74 Million | 379.15 Million | 1.6 Billion | 391.35 Million | 344.47 Million | 545.99 Million |
| Selling, General and Administrative Expenses | 136.32 Million | 132.74 Million | - | 142.7 Million | 142.47 Million | 137.72 Million |
| Research and Development Expenses | 200.41 Million | 246.4 Million | - | 248.65 Million | 201.34 Million | 408.26 Million |
| Other Expenses | 103 Thousand | 20.43 Million | -79 Thousand | 144 Thousand | 17 Thousand | 50 Thousand |
| Cost and Expenses | 393.06 Million | 451.79 Million | 1.88 Billion | 458.29 Million | 411.19 Million | 622.73 Million |
| Operating Income | -258.98 Million | -322.15 Million | -1.2 Billion | -299.85 Million | -246.06 Million | -433.25 Million |
| Interest Expense | 714 Thousand | 568 Thousand | 2.06 Million | 588 Thousand | 571 Thousand | 573 Thousand |
| Income Tax Expense | 663 Thousand | 1.25 Million | 5.01 Million | 1.25 Million | 1.25 Million | 1.25 Million |
| Earnings before Tax | -259.27 Million | -302.77 Million | -1.21 Billion | -300.3 Million | -253.55 Million | -434.72 Million |
| Net Income | -259.93 Million | -304.02 Million | -1.22 Billion | -301.55 Million | -254.81 Million | -435.97 Million |
| Earnings Per Share Basic | -4.61 | -5.60 | - | -5.83 | -5.14 | -9.00 |
| Earnings Per Share Diluted | -4.61 | -5.60 | - | -5.83 | -5.14 | -9.00 |
| Weighted Average Shares Outstanding | 56.38 Million | 54.3 Million | 49.54 Million | 51.76 Million | 49.52 Million | 48.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.38 Million | 54.3 Million | 49.54 Million | 51.76 Million | 49.52 Million | 48.46 Million |
| Gross Margin | 0.58 | 0.44 | 0.58 | 0.58 | 0.60 | 0.59 |
| EBIT Margin | -1.93 | -2.33 | - | -1.90 | -1.54 | -2.29 |
| Profit Margin | -1.94 | -2.35 | -1.79 | -1.90 | -1.54 | -2.30 |
| EBITDA | -258.68 Million | -302.45 Million | - | -300.41 Million | -253.52 Million | -434.13 Million |
| Earnings Before Tax Margin | -1.93 | -2.48 | -1.77 | -1.89 | -1.49 | -2.29 |
2507
MTL
000838
R35
HNL
AOMD